Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2017-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事关于第五届董事会第十四次会议相关事项的专项说明及独立意见
Board/Management Information Classification · 95% confidence The document is a statement from the independent directors of 嘉事堂药业股份有限公司 regarding the 14th meeting of the 5th board. It contains independent opinions on the 2016 annual audit report, internal control self-evaluation, related party transactions, use of raised funds, profit distribution proposal, and the appointment of the 2017 audit firm. The document is not the audit report itself but an independent directors' special statement and opinion on various board matters, including the audit report and other governance issues. It is a board/management related announcement rather than a full audit report or annual report. Therefore, the document fits best under Board/Management Information (MANG). The document length is 2368 characters, which is relatively short and consistent with a statement or announcement rather than a full report.
2017-04-26 Chinese
第五届董事会第十四次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the 5th Board of Directors of 嘉事堂药业股份有限公司. It includes approvals of various reports such as the 2016 Annual Board Work Report, 2016 Internal Control Self-Evaluation Report, 2016 Financial Final Report, 2016 Profit Distribution Plan, 2016 Annual Report and its summary, 2016 Social Responsibility Report, and other related matters. The document references the need for these reports to be approved at the shareholders' meeting and provides links to where the full reports can be found. The document is not the reports themselves but an official announcement of the board meeting resolutions and approvals. The length is 3557 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of board meeting resolutions and references to reports rather than the reports themselves.
2017-04-26 Chinese
关联方占用资金情况的专项审计
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the use of funds by related parties of 嘉事堂药业股份有限公司 for the fiscal year 2016. It includes an auditor's opinion, references to regulatory requirements by the China Securities Regulatory Commission, and detailed financial data on non-operating fund occupation and related party transactions. The document is titled as a "专项审计说明" (special audit explanation) and contains detailed audit findings and financial tables. It is not a full annual report but a standalone audit report focused on a specific issue, consistent with the definition of an Audit Report / Information (AR). The document length is about 4,821 characters, which is sufficient to contain substantive audit content rather than just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-04-26 Chinese
第五届监事会第十一次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th meeting of the 5th Supervisory Board of 嘉事堂药业股份有限公司. It includes approvals of various reports such as the 2016 Annual Supervisory Board Work Report, 2016 Internal Control Self-Evaluation Report, 2016 Financial Final Accounts Report, 2016 Profit Distribution Plan, and the 2016 Annual Report and its summary. However, the document itself does not contain the full annual report or detailed financial statements; instead, it references that the full 2016 Annual Report and other reports are available on an external website (巨潮资讯网). The document also mentions that these reports require shareholder approval. The length of the document is relatively short (2323 characters), and it primarily serves as an announcement of the supervisory board's resolutions and approvals rather than the full report itself. According to the "Menu vs Meal" rule, this is an announcement of reports and resolutions, not the reports themselves. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement of supervisory board meeting resolutions and report approvals without containing the full reports or detailed financial data.
2017-04-26 Chinese
关于召开2016年度股东大会的通知公告
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2016 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It includes information about the meeting time, location, voting procedures (both in-person and online), agenda items to be discussed and voted on, and instructions for shareholders on how to participate and vote. The document also contains an authorization form for proxy voting. There is no actual financial data or report content included, only the announcement and procedural details for the AGM. The document length is about 4862 characters, which is consistent with a detailed meeting notice rather than a full annual report or financial statement. Therefore, this document fits the category of AGM Information (AGM-R).
2017-04-26 Chinese
独立董事2016年度述职报告（吴剑）
Management Reports Classification · 95% confidence The document is titled as an "Independent Director 2016 Annual Report" and contains detailed descriptions of the independent director's activities, attendance at board and shareholder meetings, issuance of independent opinions on various company matters, supervision of governance and internal controls, and efforts to protect investor rights during the 2016 fiscal year. It is a narrative report on the independent director's duties and observations rather than a financial report or regulatory filing. The document length is under 5,000 characters, but it is a substantive report rather than a mere announcement. This type of document is best classified as a Management Report (MDA) because it provides detailed management-related information and oversight activities rather than financial statements or audit opinions alone.
2017-04-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.